Casdin Capital

Casdin Capital as of June 30, 2019

Portfolio Holdings for Casdin Capital

Casdin Capital holds 31 positions in its portfolio as reported in the June 2019 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Spark Therapeutics 8.5 $91M 885k 102.38
Invitae (NVTAQ) 8.4 $90M 3.8M 23.50
Blueprint Medicines (BPMC) 8.3 $89M 940k 94.33
Codexis (CDXS) 8.1 $87M 5.1M 17.05
Sage Therapeutics (SAGE) 6.8 $73M 400k 183.09
Myokardia 6.0 $64M 1.3M 50.14
Fate Therapeutics (FATE) 4.8 $52M 2.6M 20.30
Sarepta Therapeutics (SRPT) 4.8 $51M 335k 151.95
Bluebird Bio (BLUE) 4.4 $47M 373k 127.20
Alnylam Pharmaceuticals (ALNY) 4.4 $47M 650k 72.56
Magenta Therapeutics 4.2 $44M 3.0M 14.75
Biolife Solutions (BLFS) 3.7 $39M 2.4M 16.23
Audentes Therapeutics 3.4 $37M 965k 37.86
Voyager Therapeutics (VYGR) 2.9 $31M 1.1M 27.22
Agios Pharmaceuticals (AGIO) 2.3 $25M 495k 49.88
Illumina (ILMN) 2.1 $22M 60k 368.15
GenMark Diagnostics 2.0 $22M 3.4M 6.49
Adaptive Biotechnologies Cor (ADPT) 1.9 $20M 463k 43.40
Gritstone Oncology Ord (GRTS) 1.9 $20M 1.8M 11.14
Constellation Pharmceticls I 1.8 $19M 1.5M 12.28
Sangamo Biosciences (SGMO) 1.5 $17M 1.5M 10.77
Global Blood Therapeutics In 1.5 $16M 300k 52.60
Homology Medicines 1.4 $15M 745k 19.57
Editas Medicine (EDIT) 1.1 $12M 480k 24.74
Alector (ALEC) 0.9 $10M 551k 18.49
Twist Bioscience Corp (TWST) 0.8 $8.7M 300k 29.01
Denali Therapeutics (DNLI) 0.8 $8.3M 400k 20.76
Caredx (CDNA) 0.7 $7.2M 200k 35.99
Turning Point Therapeutics I 0.2 $2.4M 60k 40.70
Stoke Therapeutics (STOK) 0.2 $2.5M 85k 29.17
Orchard Therapeutics Plc ads 0.1 $1.4M 100k 13.99